WHO ICTRP trial
Effectiveness of switching to aripiprazole long-acting injection from other…
KCT0010280 · Clinical Research Information Service (CRIS) · Recruiting
Key facts
| Trial ID | KCT0010280 |
|---|---|
| Public title | Effectiveness of switching to aripiprazole long-acting injection from other long-acting injections and oral antipsychotics in patients with schizophrenia |
| Scientific title | Effectiveness of switching to aripiprazole long-acting injection from other long-acting injections and oral antipsychotics in patients with schizophrenia |
| Primary sponsor | Chonnam National University Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Recruiting |
| Study type | Interventional Study |
| Phase | Not applicable |
| Countries | Korea, Republic of |
| Conditions | Mental and behavioural disorders |
| Interventions | Drug : - Aripiprazole Monohydrate(Abilify Maintena Inj) : 300mg or 400mg , used an an IM injection into the deep deltoid or gluteus musche, 4Week intervals. - The switch to aripiprazole long-acting injection is based on a naturalistic… |
| Registration date | Mar 11, 2025 |
| Target size | 212 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: